Biodesix, Immodulon team up for pancreatic cancer treatment
The partnership will focus on the analysis of the circulating proteome of advanced pancreatic cancer patients treated with IMM-10.
Read More
Tag: Biodesix
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
